JPEO-CBRND

JPEO-CBRND

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

JPM-MCS Announces Start of Phase I Trial for Ebola Therapeutic

RFI – Contamination Indicator Decon Assurance Systems (CIDAS)

Notable Contracts: CBRN Protective Gear, Next Gen Sequencing

Joint Service Equipment Wipe for Chemical Agent Decontamination

Army Market Survey for CBRN, Biodefense Equipment

RFI – Chemical Biological Protective Shelter Production

RFI – Next Generation Diagnostic Devices for Biological Threats

Notable CBRN Contracts: JWARN Award to Northrop Grumman

Influenza Drug Under DoD Development Completes Second Clinical Trial

RFI – Nerve Agent Countermeasures in an Autoinjector

RFP – Joint Biological Tactical Detection System

RFI – Manufacturing Autoinjectors for Nerve Agent Countermeasures

Joint Strike Fighter Decontamination System Award to Steris Corporation

Joint Enterprise CBRNE Logistics Market Survey

DoD Market Survey for CBRNe Equipment Database

DoD Seeks Subscription to Database for Biopharma Reports

DoD Activates New JPM for Medical Countermeasure Systems

Army Conducting Market Research on Next-Generation Diagnostics for Biothreats

Notable Contracts: DynPort Nerve Agent Countermeasure Development

Joint Biological Tactical Detection System – Sources Sought

Biodefense Headlines – 31 March 2025